The change in muscarinic receptor subtypes in different brain regions of rats treated with fluoxetine or propranolol in a model of post-traumatic stress disorder

Behavioural Brain Research

Volumn 232, Issue 1, 2012, Pages 124-129

  Aykaç, Asli ^a   Aydin, Banu ^a   Cabadak, Hülya ^a   Gören, M Zafer ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Amygdaloid complex; Cat litter; Frontal cortex; Hippocampus; Predator scent test

Indexed keywords

FLUOXETINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; PROPRANOLOL; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; FEMALE; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; MAZE TEST; NONHUMAN; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEX DIFFERENCE; TISSUE HOMOGENATE; WESTERN BLOTTING;

ADRENERGIC BETA-ANTAGONISTS; AMYGDALA; ANIMALS; ANXIETY; BLOTTING, WESTERN; BRAIN CHEMISTRY; EXPLORATORY BEHAVIOR; FEMALE; FLUOXETINE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; ODORS; PREFRONTAL CORTEX; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SEROTONIN UPTAKE INHIBITORS; STARTLE REACTION; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL;

EID: 84860213958     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.04.002     Document Type: Article

References (44)

1. Yehuda R. Risk and resilience in posttraumatic stress disorder. Journal of Clinical Psychiatry 2004, 65:26-36.
2. Armario A., Escorihuela R.M., Nadal R. Long-term neuroendocrine and behavioral effects of a single exposure to stress in adult animals. Neuroscience and Behavioral Reviews 2008, 32:1121-1135.
3. Cohen H., Zohar J., Matar M.A. The relevance of differential response to trauma in an animal model of posttraumatic stress disorder. Biological Psychiatry 2003, 59:1208-1218.
4. Adamec R., Bartoszyk G.D., Burton P. Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats. European Journal of Pharmacology 2004, 504:65-77.
5. 1 receptors modulate anxiety-like behavior and spontaneous working memory in mice. Psychopharmacology 2004, 155:58-68.
6. Degroot A., Nomikos G.G. Fluoxetine disrupts the integration between anxiety and aversive memories. Neuropsychopharmacology 2005, 30:391-400.
7. Degroot A., Nomikos G.G. Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model. European Journal of Pharmacology 2006, 531:183-186.
8. 4 muscarinic receptor knockout mice. Molecular Psychiatry 2003, 8:673-679.
9. 1 receptors in the central nucleus of amygdala in conscious rats. European Journal of Pharmacology 1997, 333:63-67.
10. Ravindran L.N., Stein M.B. Pharmacotherapy of PTSD: premises, principles, and priorities. Brain Research 2009, 1293:24-39.
11. Ursano R.J., Bell C., Eth S., Friedman M., Norwood A., Zatzick D.F., et al. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. American Journal of Psychiatry 2004, 161:3-31.
12. Cohen H., Matar M.A., Richter-Levin G., Zohar J. The contribution of an animal model toward uncovering biological risk factors for PTSD. Annals of the New York Academy of Sciences 2006, 1071:335-350.
13. Matar M.A., Cohen H., Kaplan Z., Zohar J. The effect of early poststressor intervention with sertraline on behavioral responses in an animal model of post-traumatic stress disorder. Neuropsychopharmacology 2006, 31(12):2610-2618.
14. Mazor A., Michael A., Matar A., Kaplan Z., Kozlovsky N., Zohar J., et al. Gender-related qualitative differences in baseline and post-stress anxiety Responses are not reflected in the incidence of criterion-based PTSD-like behaviour patterns. World Journal of Biological Psychiatry 2009, 10:856-869.
15. Pelow S., Chopin P., File S.E., Briley M. Validation of open-closed arm entries in an elevated plus maze as measure of anxiety in the rat. Journal of Neuroscience Methods 1985, 14:149-167.
16. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, London. 2nd ed.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-327.
18. Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science 1987, 237:527-532.
19. Nathanson N.M. Synthesis, trafficking, and localization of muscarinic acetylcholine receptors. Pharmacology and Therapeutics 2008, 119(1):33-43.
20. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. Journal of Neuroscience 1991, 11(10):3218-3226.
21. 5 muscarinic acetylcholine receptors in peripheral tissues and brain. Life Sciences 1993, 52:441-448.
22. Flynn D.D., Ferrari-DiLeo G., Mash D.C., Levey A.I. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. Journal of Neurochemistry 1995, 64:1888-1891.
23. Levey A.I. Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease. Proceedings of the National Academy of Sciences United States of America 1996, 93(24):13541-13546.
24. Van Koppen C.J., Kaiser B. Regulation of muscarinic acethylcholine receptor signaling. Pharmacology and Therapeutics 2003, 98:197-220.
25. 4 muscarinic receptors are involved in modulation of neurotransmission at synapses of Schaffer collaterals on CA1 hippocampal neurons in rats. Journal of Neuroscience Research 2009, 87(3):691-700.
26. Ehlert F.J., Roeske W.R., Yamamura H.I. Molecular biology, pharmacology and brain distribution of subtypes of the muscarinic receptor. Neuropsychopharmacology 1999, 25:75-80.
27. Fadda F., Cocco S., Stancampiano R. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. Neuroreport 2000, 11:2265-2269.
28. Kopf S.R., Buchholzer M.L., Hilgert M., Loffelholz K., Klein J. Glucose plus choline improve passive avoidance behaviour and increase hippocampal acetylcholine release in mice. Neuroscience 2001, 103:365-371.
29. Elzinga B.M., Bremner J.D. Are the neural substrates of memory the final common pathway in posttraumatic stress disorder (PTSD)?. Journal of Affective Disorders 2002, 70(1):1-17.
30. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annual Review of Psychology 1997, 48:649-684.
31. Brand L., Groenewald I., Stein D.J., Wegener G., Harvey B.H. Stress and re-stress increases conditioned taste aversion learning in rats: possible frontal cortical and hippocampal muscarinic receptor involvement. European Journal of Pharmacology 2008, 586(1-3):205-211.
32. 5 receptors in rat brain. Molecular Pharmacology 1993, 43(2):149-157.
33. Cusack B., Nelson A., Richelson E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology 1994, 114(4):559-565.
34. Birkett M.A., Shinday N.M., Kessler E.J., Meyer J.S., Ritchie S., Rowletti J.K. Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice. Pharmacology Biochemistry and Behavior 2011, 98(4):544-551.
35. Schneider A.M., Simson P.E., Atapattu R.K., Kirby L.G. Stress-dependent impairment of passive-avoidance memory by propranolol or naloxone. Pharmacology Biochemistry and Behavior 2011, 98(4):539-543.
36. Debiec J., Bush D.E., LeDoux J.E. Noradrenergic enhancement of reconsolidation in the amygdala impairs extinction of conditioned fear in rats - a possible mechanism for the persistence of traumatic memories in PTSD. Depression and Anxiety 2011, 28(3):186-193.
37. Grissom N.M., Bhatnagar S. The basolateral amygdala regulates adaptation to stress via β-adrenergic receptor-mediated reductions in phosphorylated extracellular signal-regulated kinase. Neuroscience 2011, 178:108-122.
38. Melo T.G., Izídio G.S., Ferreira L.S., Sousa D.S., Macedo P.T., Cabral A., et al. Antidepressants differentially modify the extinction of an aversive memory task in female rats. Progress in Neuropsychopharmacology and Biological Psychiatry 2012, 37(1):33-40.
39. Javelot H., Weiner L., Terramorsi R., Rougeot C., Lalonde R., Messaoudi M. Efficacy of chronic antidepressant treatments in a new model of extreme anxiety in rats. Depression Research and Treatment 2011, 2011:531435.
40. 1 receptors. Behavioral Neuroscience 1998, 112:352-359.
41. Sienkiewicz-Jarosz H., Czlonkowska A.I., Siemiatkowski M., Maciejak P., Szyndler J., Plaznik A. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia. Journal of Neural Transmission 2000, 107:1403-1412.
42. Furey M.L., Khanna A., Hoffman E.M., Drevets W.C. Scopolamine produces larger antidepressant and antianxiety effects in women than in men. Neuropsychopharmacology 2010, 35(12):2479-2488.
43. Cannon D.M., Carson R.E., Nugent A.C., Eckelman W.C., Kiesewetter D.O., Williams J., et al. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder. Archives of General Psychiatry 2006, 63(7):741-747.
44. Comings D.E., Wu S., Rostamkhani M., McGue M., Iacono W.G., MacMurray J.P. Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in women. American Journal of Medical Genetics 2002, 114(5):527-529.